By James Lyons-Weiler, Brownstone Institute
The federal government just signaled a serious course correction on autism. In a joint appearance that felt less like a press conference and more like a policy pivot, President Donald J. Trump stood alongside HHS Secretary Robert F. Kennedy, Jr., NIH Director Jay Bhattacharya, FDA Commissioner Marty Makary, and CMS Director Mehmet Oz to outline an all-agency plan that treats autism as an urgent, tractable public-health crisis—not a career-long grant treadmill.
The package is sweeping. It elevates environmental and pharmaceutical exposures to first-class research questions, directs label changes with clinical relevance, and begins to dismantle sacred cows that have stifled honest inquiry for a generation.
The Headline Moves
Trump led with the cultural taboo: acetaminophen. He urged that during pregnancy it be used “only when medically necessary,” warned against reflexive dosing of children “every time they receive a vaccine,” and linked these positions to rising rates of autism that have “destroyed families” and imposed massive social costs. He also called for smaller vaccine doses on a more spread-out schedule, and he previewed a CDC policy modernization: the separation of MMRV into its component measles, mumps, rubella, and varicella vaccinations. He called ending the routine HepB birth dose a “revolution,” arguing that a sexually transmitted infection does not justify a blanket neonatal exposure.
Kennedy matched that candor point for point. He called the decades-long fixation on “the genetics of autism” fruitless by design, the equivalent of studying lung-cancer genomes while banning the word “cigarettes.” He announced that HHS will move on acetaminophen: FDA will require safety-label changes on acetaminophen-containing products, with specific caution in pregnancy and prudent use in children. He insisted on the “lowest effective dose” standards and promised a series of follow-on reports that will examine all plausible contributors—vaccines included—with “no taboos.” Mothers will not be gaslit. The period of neglect is over.
From Rhetoric to Levers
Makary put the FDA’s levers on the table. He announced updated labeling requirements for acetaminophen. He referenced major cohort and pooled analyses—Boston Birth Cohort, Nurses’ Health Study, and a Mount Sinai review/meta-analysis—describing the totality of evidence as consistent with causal signals for prenatal acetaminophen and neurodevelopmental outcomes, including autism. He challenged the “mindless” fever-suppression reflex that dominates pediatric practice, even noting evidence that treating fever may prolong illness in young children because fever serves a host-defense function. This is what regulatory science looks like when it remembers physiology.
Makary also announced a label change with immediate bedside implications: prescription leucovorin (folinic acid). He summarized the evidence that a subset of autistic children exhibit autoimmunity to folate receptors in the brain and reported response rates as high as two in three in studies where leucovorin was used to address cerebral folate deficiency. That label change matters because it tells clinicians: you have a defined pathway to try, with guardrails.
Oz then did something rare for CMS: he connected reimbursement to real-world evidence generation. CMS will issue guidance to states to ensure coverage and to capture outcomes data on leucovorin as the first FDA-recognized treatment pathway in autism. He cited a five-fold increase in autism diagnoses as reason enough to stop waiting for perfect RCTs before supporting access. Coverage with learning loops—long overdue.
NIH: From Slogans to Study Designs
Bhattacharya described imminent awards under the Autism Data Science Initiative—thirteen grants that foreground Exposomics to reflect the reality that autism arises from interacting factors, not single-gene myths. He emphasized collaboration with the FDA and CMS to align discovery with regulation and reimbursement so that findings cross the translational canyon. In short: design the portfolio to answer questions that matter in clinics and courts, not just in tenure files.
Vaccines: Dose, Timing, Composition
Trump pressed for recalibration: smaller doses, wider spacing, component vaccines instead of combination defaults, and an end to the rote HepB birth dose. He added a plain-spoken prompt to new parents—“When you have a baby, don’t give your baby Tylenol. At all.”—and he questioned why the pediatric vaccine schedule has expanded so aggressively. He raised the obvious political economy: profits and workflow convenience. Expect blowback. Also expect long-suppressed questions—about adjuvants, cumulative aluminum exposure, and risk stratification—to finally get oxygen.
Kennedy and Trump both flagged an HHS trajectory toward “no mercury in vaccines, and no aluminum in vaccines.” If HHS operationalizes that target—through reformulated products, biocompatible adjuvants, or true risk-stratified schedules—pediatrics will enter a safety-by-design era that should have started 20 years ago.
The Amish Reference and the Larger Frame
Trump referenced low autism rates in Amish communities to illustrate the plausibility of environmental and cultural determinants. The federal plan does not hang on that single observation; it uses it as a public primer on comparative epidemiology: if rates diverge across populations, genes alone cannot explain the pattern. That restores first principles to a field that drifted into genetic essentialism while incidence soared.
What Changes Tomorrow Morning
Physicians will practice with new information on the label of drugs they reach for every day. Parents will get permission—from the federal government, not a blog—to ask for spacing, for components rather than combinations, and for risk-aware dosing. State Medicaid programs and private plans will receive CMS guidance that reduces friction to leucovorin access and, crucially, builds a national outcomes dataset. Researchers will compete for NIH funds with exposure biology at the center, not at the margins. FDA will be expected to weigh physiologic purpose—like fever—in its benefit-risk framing, not just symptom suppression.
The Cultural Shift
Kennedy said the quiet part out loud: “No taboos.” That is the reform. For years, mothers and clinicians who reported temporal associations, biologic plausibility, and objective biomarkers were told to sit down and be grateful. Today, HHS leadership told them to stand up and bring data. You cannot fix what your culture forbids you to measure.
The Politics of Stewardship
This is not performative populism. It is administrative stewardship: align labels with evidence, align grants with real-world questions, align coverage with learning, align schedules with individualized risk. That is how you reduce pain and suffering without waiting for a generation of children to age out of the data.
The Close
Trump closed by urging fewer well-child visits clustered around vaccine appointments, a direct strike at schedule inertia. He relayed personal accounts of boys who regressed into autism and asked, candidly, why the schedule grew so large so fast. He cited profits by drug companies and doctors as a possible driver of the packed vaccine schedule.
American families have waited decades for federal health leadership to treat autism as a solvable systems problem. Today’s package does not answer every question. It does something braver: it permits the questions that matter and moves the levers that change practice while the answers come in.
No more taboo zones. No more gaslighting. No more performative genetics while incidence climbs. An uncompromising, relentless search for causes, mechanisms, and treatments—backed by labels, grants, and coverage—finally begins.

QTR’s Disclaimer: Please read my full legal disclaimer on my About page here. This post represents my opinions only. In addition, please understand I am an idiot and often get things wrong and lose money. I may own or transact in any names mentioned in this piece at any time without warning. Contributor posts and aggregated posts have been hand selected by me, have not been fact checked and are the opinions of their authors. They are either submitted to QTR by their author, reprinted under a Creative Commons license with my best effort to uphold what the license asks, or with the permission of the author.
This is not a recommendation to buy or sell any stocks or securities, just my opinions. I often lose money on positions I trade/invest in. I may add any name mentioned in this article and sell any name mentioned in this piece at any time, without further warning. None of this is a solicitation to buy or sell securities. I may or may not own names I write about and are watching. Sometimes I’m bullish without owning things, sometimes I’m bearish and do own things. Just assume my positions could be exactly the opposite of what you think they are just in case. If I’m long I could quickly be short and vice versa. I won’t update my positions. All positions can change immediately as soon as I publish this, with or without notice and at any point I can be long, short or neutral on any position. You are on your own. Do not make decisions based on my blog. I exist on the fringe. If you see numbers and calculations of any sort, assume they are wrong and double check them. I failed Algebra in 8th grade and topped off my high school math accolades by getting a D- in remedial Calculus my senior year, before becoming an English major in college so I could bullshit my way through things easier.
The publisher does not guarantee the accuracy or completeness of the information provided in this page. These are not the opinions of any of my employers, partners, or associates. I did my best to be honest about my disclosures but can’t guarantee I am right; I write these posts after a couple beers sometimes. I edit after my posts are published because I’m impatient and lazy, so if you see a typo, check back in a half hour. Also, I just straight up get shit wrong a lot. I mention it twice because it’s that important.



This is a good news/bad news event. The good news is that the medical profession is finally starting to address the causes and assign responsibility for causing mental retardation (a.k.a. autism).
Acetaminophen has long been known to cause liver failure, so stopping people from gobbling them like candy whenever they get a sore throat is a good thing. And “looking at” the gallons (exaggeration) of childhood vaccines shot into newborns is good, too, since that is the primary cause of their neurological damage (links below).
The bad news is that the person who brought the devastating mRNA COVID “vaccines” to market at “Warp Speed” — years before their safety and efficacy could be demonstrated — is not the right person to be the face of this effort. Hell, you may as well have Fauci talking about autism, since both he AND Trump have never apologized for the depopulation shots they together foisted on the world.
As far as Tylenol “causing” autism, I’m skeptical. They may as well have said that eating spaghetti causes autism, since almost all pregnant women eat spaghetti at least once during their 9-month gestation period. What has been proven to trigger neurological damage and cause mental retardation (autism) is the “Warp Speed” childhood vaccine schedule. We’ve gone from 5 or 6 vaccines in the first year of life to 25 or more in the first 6 months. This includes shots that make no sense, like Hepatitis B shots when the mother tests negative for Hep B. (Newborns do not shoot street drugs or have sex with hookers, which is the only way they can get Hep B if their mother doesn’t have it at birth.)
If you’re done “trusting the government” and really want to learn the cause of the exploding incidence of autism, read these reports by a respected physician:
https://www.midwesterndoctor.com/p/why-do-vaccines-cause-autism
https://www.midwesterndoctor.com/p/the-forgotten-tragedy-of-neurological
https://www.midwesterndoctor.com/p/yales-censored-vaccine-injury-research
https://www.midwesterndoctor.com/p/erasing-encephalitis-why-vaccine
“The government is here to help.” What a load of BS. They are so levered up by big pharma and the AMA that there is no daylight at the end of tunnel. Said tunnel caved in long ago.